GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: 4(1MeW) [2] | POT-4
                                 
                                                         
                            
                            
                            
                                Compound class: 
                                                            Peptide
                                 
                                
                                    
                                        Comment: AL-78898A is an investigational analogue of compstatin [2], which acts as an irreversible inhibitor of complement component 3 (C3). C3 inhibitors are being actively investigated for clinical potential in inflammatory and degenerative diseases [1].
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                     | 
                                    
| References | 
| 
                                                                         1. Morgan BP, Harris CL. (2015)
                                         Complement, a target for therapy in inflammatory and degenerative diseases. Nat Rev Drug Discov, 14 (12): 857-77. [PMID:26493766]  | 
                                                                
| 
                                                                         2. Qu H, Ricklin D, Bai H, Chen H, Reis ES, Maciejewski M, Tzekou A, DeAngelis RA, Resuello RR, Lupu F et al.. (2013)
                                         New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic properties. Immunobiology, 218 (4): 496-505. [PMID:22795972]  |